Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Lineage Cell Therapeutics
AddedFeb 19, 2024
UpdatedJun 28, 2026
Lineage Cell Therapeutics

Lineage Cell Therapeutics

Public

Lineage Cell Therapeutics, a US biotech firm, offers cell-based therapies and molecular diagnostics for degenerative conditions.

HQ
Carlsbad, CA, US
Founded
1990
Overview
Compare
Fundraising
Employees
Website

Lineage Cell Therapeutics, founded in the United States, is a biotechnology company dedicated to pioneering a new branch of medicine through cell-based therapies and gene marker-based molecular diagnostics. The company's core mission is to develop and deliver innovative treatments for degenerative conditions by transplanting specific cell types to patients with serious medical conditions. Lineage's product pipeline includes therapies targeting eye diseases, among other degenerative conditions, with a focus on improving patient outcomes through advanced biotechnological solutions.

Notable affiliations include a collaboration with Genentech to develop allogeneic retinal pigment epithelial (RPE) cells for treating eye diseases. Key achievements for Lineage Cell Therapeutics include advancing their cell therapy pipeline and establishing significant partnerships within the biotech industry. The company's impact lies in its potential to revolutionize treatment paradigms for degenerative diseases, offering hope and improved quality of life for patients suffering from these conditions.

Lineage Cell Therapeutics - Similar Companies

Celularity logo

Celularity

celularity.com

Legend Biotech logo

Legend Biotech

legendbiotech.com

Cell Care Therapeutics logo

Cell Care Therapeutics

cell-care.com

Platelet BioGenesis logo

Platelet BioGenesis

Stemedica Cell Technologies logo

Stemedica Cell Technologies

stemedica.com

U.S. Stem Cell logo

U.S. Stem Cell

us-stemcell.com

International Stem Cell logo

International Stem Cell

EyeCyte logo

EyeCyte

eyecyte.com

jCyte logo

jCyte

jcyte.com

AgeX Therapeutics logo

AgeX Therapeutics

ViaCyte logo

ViaCyte

Longeveron logo

Longeveron

longeveron.com

HebeCell logo

HebeCell

hebecellcorp.com

Pathfinder Cell Therapy logo

Pathfinder Cell Therapy

Cellular Approaches logo

Cellular Approaches

Lineage Cell Therapeutics - Quick Facts

Who are Lineage Cell Therapeutics' competitors?

Companies similar to Lineage Cell Therapeutics include Celularity, Legend Biotech, Cell Care Therapeutics and Platelet BioGenesis.

When was Lineage Cell Therapeutics founded?

Lineage Cell Therapeutics was founded in 1990.

Where is Lineage Cell Therapeutics' headquarters located?

Lineage Cell Therapeutics' headquarters is located in Carlsbad, CA, US.

How much has Lineage Cell Therapeutics raised to-date?

As of May 9, 2023, Lineage Cell Therapeutics has raised a total of $115.3M (USD).

How many employees does Lineage Cell Therapeutics have?

Lineage Cell Therapeutics has 55 employees as of Feb 6, 2024.

Lineage Cell Therapeutics - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Cell Therapies
  • Molecular Diagnostics
Tags
  • Healthtech
Unique IDs
  • ein: 943127919
  • secCik: 0000876343
  • ticker: LCTX
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 2830Drugs
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research